IBSA USA
Keith Ciucci is a seasoned sales professional with extensive experience in the pharmaceutical industry, currently serving as a Specialty Sales Representative at IBSA USA since July 2022. Prior to this role, Keith excelled as a Cardiovascular Sales Professional at Amarin Pharmaceuticals Inc., where recognition included the 2021 Circle of Excellence Winner for the highest TRx Growth in the nation and designation as Regional Field Trainer. Previous positions include ADHD Specialty Sales Professional at Ironshore Pharmaceuticals Inc., where Keith won a district award for new writer generation, and Territory Manager at Arbor Pharmaceuticals, achieving notable sales growth and rankings during tenure. Keith's career began as a Personal Trainer at Wheaton Sport Center. Academically, Keith holds an MBA in Management and a B.S. in Physical Education from Illinois State University.
This person is not in any teams
IBSA USA
IBSA USA is the subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. IBSA is committed to improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets two unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA also markets Licart™ (diclofenac epolamine) topical system 1.3%, the only once-a-day topical nonsteroidal anti-inflammatory (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. IBSA is focused on the health and well-being of patients and driven by the desire to bring therapeutic alternatives to as many people as possible. IBSA Group bases its philosophy on four sustainable pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, go to each brand’s respective website.